Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma
Cancer Immunology, Immunotherapy · 19.11.2026
DOI: 10.1007/s00262-026-04642-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 19.11.2026. Verfasst von Wenhao Niu und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Niu, W., Wang, B., Zhang, Y., Cao, J., Li, J., Xu, K., Lv, Y., Xiao, J., Li, M., Wang, T., He, Y., & Lei, P. (2026). Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04642-2
Vancouver
Niu W, Wang B, Zhang Y, Cao J, Li J, Xu K, et al. Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04642-2
BibTeX
@article{Niu2026,
author = {Niu, Wenhao and Wang, Binchen and Zhang, Yirui and Cao, Jing and Li, Jiali and Xu, Kui and Lv, Yibing and Xiao, Junyi and Li, Mingxuan and Wang, Tingting and He, Yong and Lei, Ping},
title = {Sequential use of fibroblast activation protein targeted radiotherapy and CAR-T therapy enhances the anti-tumor response in pancreatic ductal adenocarcinoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04642-2}
}
EUVIMED